Gavin Wood, Chief Financial Officer at Adaptimmune Therapeutics PLC (ADAP), bought 33,000 shares at $1.62 ($53K) on 2020-06-29, disclosed to the SEC on 2020-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADAP | BUY | 2020-12-16 | $17K | — | Filing → |
| AFFX | SELL | 2015-02-18 | $15K | — | Filing → |
| AFFX | SELL | 2015-01-21 | $265K | — | Filing → |